HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
G Calvaruso Selected Research
G Calvaruso Research Topics
Disease
4
Neoplasms (Cancer)
09/2015 - 04/2006
4
Hepatocellular Carcinoma (Hepatoma)
05/2010 - 10/2002
3
Osteosarcoma (Osteogenic Sarcoma)
03/2009 - 06/2001
2
Carcinoma (Carcinomatosis)
03/2009 - 10/2007
2
Retinoblastoma (Glioblastoma, Retinal)
06/2001 - 11/2000
1
Macrocytic Anemia
06/2016
1
Hemolytic Anemia
06/2016
1
Congenital Dyserythropoietic Anemia (Dyserythropoietic Anemia, Congenital)
06/2016
1
Thalassemia
02/2016
1
beta-Thalassemia (Cooley's Anemia)
02/2016
1
Necrosis
05/2010
1
Breast Neoplasms (Breast Cancer)
03/2009
1
Liver Neoplasms (Liver Cancer)
04/2006
1
Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
09/2004
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
09/2004
1
Hepatoblastoma
10/2002
Drug/Important Bio-Agent (IBA)
3
Proteasome Inhibitors
IBA
04/2006 - 10/2002
3
benzyloxycarbonylleucyl-leucyl-leucine aldehyde
IBA
08/2003 - 11/2000
2
beta-Globins (beta Globin)
IBA
06/2016 - 02/2016
2
Globins
IBA
06/2016 - 02/2016
2
Cisplatin (Platino)
FDA Link
Generic
03/2009 - 10/2007
2
ATP dependent 26S protease (26S proteasome)
IBA
10/2002 - 11/2000
2
Camptothecin
IBA
06/2001 - 11/2000
2
Topoisomerase I Inhibitors
IBA
06/2001 - 06/2001
1
Chromatin
IBA
06/2016
1
Iron
IBA
06/2016
1
Heterochromatin
IBA
06/2016
1
Nucleotides
IBA
02/2016
1
3' Untranslated Regions (3' UTR)
IBA
02/2016
1
caffeic acid
IBA
09/2015
1
di-n-butyltin (dibutyltin)
IBA
09/2015
1
dibutyl(caffeic acid)tin(IV)
IBA
09/2015
1
CCAAT-Enhancer-Binding Proteins
IBA
05/2010
1
(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)
IBA
05/2010
1
Cannabinoids
IBA
05/2010
1
Ligands
IBA
05/2010
1
Mesylates (Mesylate)
IBA
05/2010
1
Proteins (Proteins, Gene)
FDA Link
05/2010
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
05/2010
1
TNF-Related Apoptosis-Inducing Ligand Receptors
IBA
05/2010
1
Platinum
IBA
03/2009
1
Bortezomib (Velcade)
FDA Link
04/2006
1
Alemtuzumab (Campath)
FDA Link
09/2004
1
Steroids
IBA
09/2004
1
Hydrogen Peroxide (Hydroperoxide)
FDA Link
Generic
10/2002
1
Caspase 3 (Caspase-3)
IBA
10/2002
1
JNK Mitogen-Activated Protein Kinases
IBA
06/2001
1
Topotecan (Hycamtin)
FDA Link
Generic
06/2001
1
4-phenylbutyric acid (Buphenyl)
FDA Link
06/2001
1
Type I DNA Topoisomerases (Topoisomerase I)
IBA
11/2000
1
Butyric Acid (Butanoic Acid)
IBA
11/2000
Therapy/Procedure
1
Therapeutics
09/2015